(CNN) - Patients in the United States can now get the popular diabetes and weight loss drug Ozempic for half the price. Novo ...

The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes ...

Wall Street held near its record heights on Monday, ahead of a week likely to be dominated by updates from the head of the ...

Novo Nordisk (NYSE:NVO) is one of the Most Profitable Large Cap Stocks to Buy According to Analysts. On August 15, Novo ...

The clinical-stage biotech, closely watched by some because of its investigational weight-loss drug VK2735, saw its share ...

Dow Jones Top Company Headlines at 9 PM ET: SoftBank Invests $2 Billion in Intel as U.S. Considers Taking 10% Stake in Chip Maker | BHP ... SoftBank Invests $2 Billion in Intel as U.S. Considers ...

These Stocks Moved Moving the Most Today: Dayforce, Novo Nordisk, GoodRx, UnitedHealth, Sunrun, Duolingo, TeraWulf, and More ...

The detention facility operator named Patrick Swindle as its next chief executive officer, succeeding long-time executive Damon Hininger, who will continue at the company under a transition agreement.

Novo Nordisk announced Monday that US patients can now get a month’s supply of Ozempic, the blockbuster diabetes drug, for ...

U.S. District Judge Karen Marston, of the Eastern District of Pennsylvania, allowed some misrepresentation claims to go ...